Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations

Cancer Research

Volumn 73, Issue 11, 2013, Pages 3441-3450

  Price, Richard L ^a   Song, Jieun ^a,b   Bingmer, Katherine ^a   Kim, Tae Hyong ^a,b   Yi, Ji Yeun ^a,b   Nowicki, Michal O ^c   Mo, Xiaokui ^a   Hollon, Todd ^a   Murnan, Eric ^a,b   Alvarez Breckenridge, Christopher ^a   Fernandez, Soledad ^a   Kaur, Balveen ^a   Rivera, Andreana ^a   Oglesbee, Michael ^a   Cook, Charles ^a   Chiocca, E Antonio ^a,c   Kwon, Chang Hyuk ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CANCER GROWTH; CAUSAL ATTRIBUTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION; GENE MUTATION; GLIOBLASTOMA; GROWTH INHIBITION; HIPPOCAMPUS; HUMAN; IMMUNOREACTIVITY; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SUBVENTRICULAR ZONE; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE; VIRUS REPLICATION;

ANIMALS; BRAIN DISEASES; BRAIN NEOPLASMS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; MALE; MICE; NIH 3T3 CELLS; PREGNANCY; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSION, GENETIC; VIRUS REPLICATION;

EID: 84878613012     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-3846     Document Type: Article

References (40)

1. TCGA-Research-Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455:1061-8.
2. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807-12.
3. Kleihues P, CaveneeWKeditors. Pathology and genetics of tumours of the nervous system. Lyon, France: IARC Press; 2000.
4. Kwon C-H. Pten-deficient mouse models for high-grade astrocytomas. In: Meir EV editor. CNS cancer: models, markers, prognostic factors, targets, and therapeutic approaches. New York, NY: Humana Press; 2009, p. 77-92.
5. Miller G. A viral link to glioblastoma? Science 2009;323:30-1.
6. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002;62:3347-50.
7. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 2008;116:79-86.
8. Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 2008;10:10-8.
9. Prins RM, Cloughesy TF, Liau LM. Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med 2008;359:539-41.
10. Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, et al. Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 2005;18:838-43.
11. Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer Jr. Lack of association of herpesviruses with brain tumors. J Neurovirol 2006;12:90-9.
12. Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Tremoulet M, et al. Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 2005;92:747-50.
13. Cinatl J, Scholz M, Kotchetkov R, Vogel JU, Doerr HW. Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med 2004;10:19-23.
14. Soroceanu L, Cobbs CS. Is HCMV a tumor promoter? Virus Res 2011; 157:193-203.
15. Bongers G, Maussang D, Muniz LR, Noriega VM, Fraile-Ramos A, Barker N, et al. The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. J Clin Invest 2010;120:3969-78.
16. Jones CA. Congenital cytomegalovirus infection. Curr Probl Pediatr Adolesc Health Care 2003;33:70-93.
17. Sinzger C, Jahn G. Human cytomegalovirus cell tropism and pathogenesis. Intervirology 1996;39:302-19.
18. Rawlinson WD, Farrell HE, Barrell BG. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 1996;70:8833-49.
19. Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NK. Murine model of cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 2008;325:315-31.
20. Tsutsui Y, Kashiwai A, Kawamura N, Aiba-Masago S, Kosugi I. Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre-and perinatal infection. Arch Virol 1995;140:1725-36.
21. Bubic I, Wagner M, Krmpotic A, Saulig T, Kim S, Yokoyama WM, et al. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 2004;78:7536-44.
22. Klenovsek K, Weisel F, Schneider A, Appelt U, Jonjic S, Messerle M, et al. Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 2007;110:3472-9.
23. Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A 2003;100:14976-81.
24. Britt WJ. Human cytomegalovirus: propagation, quantification, and storage. Curr Protoc Microbiol 2010;Chapter 14:Unit 14E.3.
25. Terada K, Wakimoto H, Tyminski E, Chiocca EA, Saeki Y. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models. Gene Ther 2006;13:705-14.
26. Nakano I, Joshi K, Visnyei K, Hu B, Watanabe M, Lam D, et al. Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway. Neuro Oncol 2011;13:622-34.
27. Kwon CH, Zhao D, Chen J, Alcantara S, Li Y, Burns DK, et al. Pten haploinsufficiency accelerates formation of high grade astrocytomas. Cancer Res 2008;68:3286-94.
28. Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, Li Y, Burns DK, et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009;15:45-56.
29. Fraser MM, Zhu X, Kwon CH, Uhlmann EJ, Gutmann DH, Baker SJ. Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res 2004;64:7773-9.
30. Ben-Hur T, Rosen-Wolff A, Lamade W, Darai G, Becker Y. HSV-1 DNA sequence determining intraperitoneal pathogenicity in mice is required for transcription of viral immediate-early genes in macrophages. Virology 1988;163:397-404.
31. Chen J, Kwon CH, Lin L, Li Y, Parada LF. Inducible site-specific recombination in neural stem/progenitor cells. Genesis 2009;47: 122-31.
32. Trgovcich J, Stimac D, Polic B, Krmpotic A, Pernjak-Pugel E, Tomac J, et al. Immune responses and cytokine induction in the development of severe hepatitis during acute infections with murine cytomegalovirus. Arch Virol 2000;145:2601-18.
33. Kim TH, Song J, Alcantara Llaguno SR, Murnan E, Liyanarachchi S, Palanichamy K, et al. Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growth. PLoS One 2012;7:e42818.
34. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010;463:318-25.
35. Brantley EC, Benveniste EN. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 2008;6:675-84.
36. Slinger E, Maussang D, Schreiber A, Siderius M, Rahbar A, Fraile-Ramos A, et al. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 2010;3: ra58.
37. Dziurzynski K, Wei J, Qiao W, Hatiboglu MA, Kong LY, Wu A, et al. Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin Cancer Res 2011;17:4642-9.
38. Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002;360: 1557-63.
39. Harkins LE, Matlaf LA, Soroceanu L, Klemm K, Britt WJ, Wang W, et al. Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae 2010;1:8.
40. Baryawno N, Rahbar A, Wolmer-Solberg N, Taher C, Odeberg J, Darabi A, et al. Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest 2011;121:4043-55.